U.S., July 19 -- ClinicalTrials.gov registry received information related to the study (NCT07072611) titled 'Clinical Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of SOF-SKN in Healthy Participants' on June 16.
Brief Summary: The goal of this study is to investigate the safety and tolerability of the topical application of SOF-SKN in healthy volunteers. The study will be divided into part 1 and part 2.
Part 1, is a single ascending dose (SAD) design, while Part 2 is a multiple ascending dose (MAD) design.
Study Start Date: July, 2025
Study Type: INTERVENTIONAL
Condition:
Cutaneous Lupus Erythematosus
Intervention:
DRUG: SOF-SKN 0.25%
cream for topical application
DRUG: SOF-SKN 0.5%
cream for topical application
D...